HomeMarkets Markets Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion as experimental treatments gain traction By news July 17, 2026 0 106 FacebookTwitterPinterestWhatsApp Eli Lilly will acquire psychedelic drugmaker AtaiBeckley for $2.8 billion up front, the company said Thursday, as momentum grows for using versions …This post was originally published on this site Share FacebookTwitterPinterestWhatsApp Subscribe Login Notify of new follow-up comments new replies to my comments Please login to comment 0 Comments Inline Feedbacks View all comments Stay Connected148,415FansLike396,312FollowersFollow3,260SubscribersSubscribe Latest Articles Markets Iran war costs $38 billion as CBO warns of higher inflation, depleted weapons Markets The US says it has launched ‘space control weapons’. It plays into the hands of its enemies Market News Crypto bill collapses on Senate floor Market News Iran war has cost taxpayers $38B — and counting Markets PhilStockWorld September Portfolio Review (Members Only) Markets Supreme Court Rejects Trump’s Effort to Break Vote-By-Mail Before Midterms Market News Fed poised to clash with Trump Markets Downside Protection Strategies for Stocks: How to Trade Like ‘The House’ in 2026 Market News It Sure Looks Like Trump and His Sons Are About to Dump Their Crypto Energy Houthi rebels’ control of Red Sea oil chokepoint exposes deep divisions in Brics AI Why stocks are shrugging off rising interest rates AI The MAGA Plot(s) to Destroy Humanity Market News Donald Trump Jr.’s Wedding Bankrolled by Putin-Linked Russian Oligarch Market News MAGA Is Making the World Safe for Corruption (updated, shared) Load more